Use of cyclosporin a in establishing epstein-barr virus-transformed human lymphoblastoid cell lines

Abstract
Summary We have investigated the potential for using cyclosporin A to increase the efficiency with which Epstein-Barr virus-transformed human lymphoblast lines can be prepared. Use of this immunosuppressive drug has permitted the development of a procedure with success rates exceeding 95% despite the processing of very large numbers of samples.